101 related articles for article (PubMed ID: 15010897)
61. Genetic instability in human mismatch repair deficient cancers.
Duval A; Hamelin R
Ann Genet; 2002; 45(2):71-5. PubMed ID: 12119215
[TBL] [Abstract][Full Text] [Related]
62. Somatic mutation profiles of clear cell endometrial tumors revealed by whole exome and targeted gene sequencing.
Le Gallo M; Rudd ML; Urick ME; Hansen NF; Zhang S; ; Lozy F; Sgroi DC; Vidal Bel A; Matias-Guiu X; Broaddus RR; Lu KH; Levine DA; Mutch DG; Goodfellow PJ; Salvesen HB; Mullikin JC; Bell DW
Cancer; 2017 Sep; 123(17):3261-3268. PubMed ID: 28485815
[TBL] [Abstract][Full Text] [Related]
63. Analysis of MSH3 in endometrial cancers with defective DNA mismatch repair.
Swisher EM; Mutch DG; Herzog TJ; Rader JS; Kowalski LD; Elbendary A; Goodfellow PJ
J Soc Gynecol Investig; 1998; 5(4):210-6. PubMed ID: 9699180
[TBL] [Abstract][Full Text] [Related]
64. Mismatch repair deficiency endows tumors with a unique mutation signature and sensitivity to DNA double-strand breaks.
Zhao H; Thienpont B; Yesilyurt BT; Moisse M; Reumers J; Coenegrachts L; Sagaert X; Schrauwen S; Smeets D; Matthijs G; Aerts S; Cools J; Metcalf A; Spurdle A; ; Amant F; Lambrechts D
Elife; 2014 Aug; 3():e02725. PubMed ID: 25085081
[TBL] [Abstract][Full Text] [Related]
65. Microsatellite instability derived JAK1 frameshift mutations are associated with tumor immune evasion in endometrioid endometrial cancer.
Stelloo E; Versluis MA; Nijman HW; de Bruyn M; Plat A; Osse EM; van Dijk RH; Nout RA; Creutzberg CL; de Bock GH; Smit VT; Bosse T; Hollema H
Oncotarget; 2016 Jun; 7(26):39885-39893. PubMed ID: 27213585
[TBL] [Abstract][Full Text] [Related]
66. Re: Tomlinson et al. Does MSI-low exist. J Pathol 2002; 197: 6-13.
Jass JR
J Pathol; 2003 Feb; 199(2):267-9; author reply 269-70. PubMed ID: 12533841
[No Abstract] [Full Text] [Related]
67. High frequency strand slippage mutations in CTCF in MSI-positive endometrial cancers.
Zighelboim I; Mutch DG; Knapp A; Ding L; Xie M; Cohn DE; Goodfellow PJ
Hum Mutat; 2014 Jan; 35(1):63-5. PubMed ID: 24130125
[TBL] [Abstract][Full Text] [Related]
68. Endometrial cancer and microsatellite instability status.
Kanopiene D; Vidugiriene J; Valuckas KP; Smailyte G; Uleckiene S; Bacher J
Open Med (Wars); 2015; 10(1):70-76. PubMed ID: 28352680
[TBL] [Abstract][Full Text] [Related]
69. Low mutation incidence in polymorphic noncoding short mononucleotide repeats in gastrointestinal cancer of the microsatellite mutator phenotype pathway.
Suzuki K; Dai T; Suzuki I; Dai Y; Yamashita K; Perucho M
Cancer Res; 2002 Apr; 62(7):1961-5. PubMed ID: 11929811
[TBL] [Abstract][Full Text] [Related]
70. A novel immune-related gene signature for diagnosis and potential immunotherapy of microsatellite stable endometrial carcinoma.
Xiao Y; Yu X; Wang Y; Song G; Liu M; Wang D; Wang H
Sci Rep; 2024 Feb; 14(1):3738. PubMed ID: 38355782
[TBL] [Abstract][Full Text] [Related]
71. The mutator pathway is a feature of immunodeficiency-related lymphomas.
Duval A; Raphael M; Brennetot C; Poirel H; Buhard O; Aubry A; Martin A; Krimi A; Leblond V; Gabarre J; Davi F; Charlotte F; Berger F; Gaidano G; Capello D; Canioni D; Bordessoule D; Feuillard J; Gaulard P; Delfau MH; Ferlicot S; Eclache V; Prevot S; Guettier C; Lefevre PC; Adotti F; Hamelin R
Proc Natl Acad Sci U S A; 2004 Apr; 101(14):5002-7. PubMed ID: 15047891
[TBL] [Abstract][Full Text] [Related]
72. Sequencing of candidate chromosome instability genes in endometrial cancers reveals somatic mutations in ESCO1, CHTF18, and MRE11A.
Price JC; Pollock LM; Rudd ML; Fogoros SK; Mohamed H; Hanigan CL; Le Gallo M; ; Zhang S; Cruz P; Cherukuri PF; Hansen NF; McManus KJ; Godwin AK; Sgroi DC; Mullikin JC; Merino MJ; Hieter P; Bell DW
PLoS One; 2014; 8(6):e63313. PubMed ID: 23755103
[TBL] [Abstract][Full Text] [Related]
73. The different effects of apoptosis and DNA repair on tumorigenesis.
Plotkin JB; Nowak MA
J Theor Biol; 2002 Feb; 214(3):453-67. PubMed ID: 11846602
[TBL] [Abstract][Full Text] [Related]
74. Inactivation of DNA repair-prospects for boosting cancer immune surveillance.
Truini A; Germano G; Bardelli A
Genome Med; 2018 Nov; 10(1):91. PubMed ID: 30486892
[TBL] [Abstract][Full Text] [Related]
75. Diverse mutational signatures in endometrial cancer: implications for tumor etiology and evolution.
Rush CM; Goodfellow PJ
Gynecol Oncol; 2019 Jan; 152(1):1-2. PubMed ID: 30611321
[No Abstract] [Full Text] [Related]
76. Gynecological Cancers Caused by Deficient Mismatch Repair and Microsatellite Instability.
Deshpande M; Romanski PA; Rosenwaks Z; Gerhardt J
Cancers (Basel); 2020 Nov; 12(11):. PubMed ID: 33182707
[TBL] [Abstract][Full Text] [Related]
77. MonoSeq Variant Caller Reveals Novel Mononucleotide Run Indel Mutations in Tumors with Defective DNA Mismatch Repair.
Walker CJ; Miranda MA; O'Hern MJ; Blachly JS; Moyer CL; Ivanovich J; Kroll KW; Eisfeld AK; Sapp CE; Mutch DG; Cohn DE; Bundschuh R; Goodfellow PJ
Hum Mutat; 2016 Oct; 37(10):1004-12. PubMed ID: 27346418
[TBL] [Abstract][Full Text] [Related]
78. Apoptotic and growth regulatory genes as mutational targets in mismatch repair deficient endometrioid adenocarcinomas of young patients.
Vassileva V; Millar A; Briollais L; Chapman W; Bapat B
Oncol Rep; 2004 Apr; 11(4):931-7. PubMed ID: 15010897
[TBL] [Abstract][Full Text] [Related]
79. Genes involved in DNA repair are mutational targets in endometrial cancers with microsatellite instability.
Vassileva V; Millar A; Briollais L; Chapman W; Bapat B
Cancer Res; 2002 Jul; 62(14):4095-9. PubMed ID: 12124347
[TBL] [Abstract][Full Text] [Related]
80. Pathogenesis of DNA repair-deficient cancers: a statistical meta-analysis of putative Real Common Target genes.
Woerner SM; Benner A; Sutter C; Schiller M; Yuan YP; Keller G; Bork P; Doeberitz Mv; Gebert JF
Oncogene; 2003 Apr; 22(15):2226-35. PubMed ID: 12700659
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
